Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity ; day:1 ; month:12 ; year:2020 ; pages:1-21
Rheumatology and therapy ; (1.12.2020), 1-21
- Creator
-
Huizinga, Tom W. J.
Torii, Yoshifumi
Muniz, Rafael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-020-00259-8
- URN
-
urn:nbn:de:101:1-2021011021064743436021
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huizinga, Tom W. J.
- Torii, Yoshifumi
- Muniz, Rafael
- SpringerLink (Online service)
Other Objects (12)
Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Beyond the joints in rheumatoid arthritis : effects of adalimumab on hematologic and lipid indices
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Beyond the joints in rheumatoid arthritis : effects of adalimumab on hematologic and lipid indices
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars
Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Beyond the joints in rheumatoid arthritis : effects of adalimumab on hematologic and lipid indices
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis